{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:59:03Z","timestamp":1771887543844,"version":"3.50.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,28]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Acute pancreatitis (AP) is a common emergency condition with high morbidity, mortality, and socio-economic impact. Soluble urokinase plasminogen activator receptor (suPAR) is a potential biomarker for AP prognosis. This study systematically reviews the literature on suPAR\u2019s prognostic roles in assessing AP severity, organ failure, mortality, and other pathological markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive search of 5 databases up to March 19, 2023, was conducted, selecting cohort studies that examined suPAR\u2019s relationship with AP outcomes. Outcome variables included AP severity, organ failure, mortality, hospital stay length, and suPAR\u2019s association with other inflammatory markers. Our paper has been registered on Prospero (ID: CRD42023410628).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Nine prospective observational studies with 1033 AP patients were included. Seven of eight studies found suPAR significantly elevated in severe acute pancreatitis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). Four studies showed suPAR effectively predicted organ failure risk, and 4 studies concluded suPAR significantly predicted mortality (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). The review had no high-risk studies, enhancing credibility.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>suPAR is a valuable prognostic marker in AP, significantly predicting severity, organ failure, hospital stay length, and mortality. Further large-scale studies are needed to explore suPAR\u2019s role in other clinical outcomes related to AP disease course, to establish it as a mainstay of AP prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000037064","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T14:54:19Z","timestamp":1719586459000},"page":"e37064","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic role of suPAR in acute pancreatitis: A protocol for systematic review"],"prefix":"10.1097","volume":"103","author":[{"given":"Syeda Tayyaba","family":"Rehan","sequence":"first","affiliation":[{"name":"Department of Medicine, Dow University of Health Science, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laiba","family":"Imran","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Science, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farea","family":"Eqbal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Science, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zayeema","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Science, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulqadir J.","family":"Nashwan","sequence":"additional","affiliation":[{"name":"Hamad Medical Corporation, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6705-2030","authenticated-orcid":false,"given":"Muhammad Sohaib","family":"Asghar","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260223","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018 [published correction appears in Gastroenterology. 2019 May;156(6):1936].","volume":"156","author":"Peery","year":"2019","journal-title":"Gastroenterology"},{"key":"R2-20260223","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41575-018-0087-5","article-title":"Global epidemiology and holistic prevention of pancreatitis.","volume":"16","author":"Petrov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R4-20260223","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.hpb.2018.08.003","article-title":"A systematic review and meta-analysis of the aetiology of acute pancreatitis.","volume":"21","author":"Zilio","year":"2019","journal-title":"HPB (Oxford)"},{"key":"R5-20260223","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/jvim.16437","article-title":"New insights into the etiology, risk factors, and pathogenesis of pancreatitis in dogs: potential impacts on clinical practice.","volume":"36","author":"Cridge","year":"2022","journal-title":"J Vet Intern Med"},{"key":"R6-20260223","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/medicina58060787","article-title":"Predicting severity of acute pancreatitis.","volume":"58","author":"Lee","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"R8-20260223","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1111\/j.1572-0241.2006.00856.x","article-title":"Practice guidelines in acute pancreatitis.","volume":"101","author":"Banks","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R9-20260223","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/gastro\/gov009","article-title":"Predicting morbidity and mortality in acute pancreatitis in an Indian population: a comparative study of the BISAP score, Ranson\u2019s score and CT severity index.","volume":"4","author":"Yadav","year":"2016","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"R10-20260223","article-title":"BioRender."},{"key":"R11-20260223","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/ijms21010338","article-title":"Multifactorial scores and biomarkers of prognosis of acute pancreatitis: applications to research and practice.","volume":"21","author":"Silva-Vaz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R12-20260223","doi-asserted-by":"crossref","first-page":"780641","DOI":"10.3389\/fimmu.2021.780641","article-title":"Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a biomarker of systemic chronic inflammation.","volume":"12","author":"Rasmussen","year":"2021","journal-title":"Front Immunol"},{"key":"R13-20260223","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/10408363.2016.1269310","article-title":"The intriguing role of soluble urokinase receptor in inflammatory diseases.","volume":"54","author":"Desmedt","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R14-20260223","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12873-021-00544-x","article-title":"suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department.","volume":"21","author":"Santeri","year":"2021","journal-title":"BMC Emerg Med"},{"key":"R15-20260223","first-page":"650","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update.","volume":"13","author":"Velissaris","year":"2022","journal-title":"Caspian J Intern Med"},{"key":"R16-20260223","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pan.2016.11.005","article-title":"Soluble urokinase-type plasminogen activator receptor (suPAR) in patients with acute pancreatitis (AP) - progress in prediction of AP severity.","volume":"17","author":"Lipinski","year":"2017","journal-title":"Pancreatology"},{"key":"R17-20260223","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MPA.0000000000000730","article-title":"Plasma level of soluble urokinase-type plasminogen activator receptor predicts the severity of acute alcohol pancreatitis.","volume":"46","author":"Nikkola","year":"2017","journal-title":"Pancreas"},{"key":"R18-20260223","doi-asserted-by":"crossref","first-page":"W-65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"R19-20260223","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejim.2019.04.007","article-title":"Plasma level of soluble urokinase plasminogen activator receptor (suPAR) predicts long-term mortality after first acute alcohol-induced pancreatitis.","volume":"64","author":"Aronen","year":"2019","journal-title":"Eur J Intern Med"},{"key":"R20-20260223","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MPA.0000000000001247","article-title":"Correlation of serum and ascitic fluid soluble form urokinase plasminogen activator receptor levels with patient complications, disease severity, inflammatory markers, and prognosis in patients with severe acute pancreatitis.","volume":"48","author":"Long","year":"2019","journal-title":"Pancreas"},{"key":"R21-20260223","doi-asserted-by":"crossref","first-page":"e23097","DOI":"10.1002\/jcla.23097","article-title":"Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.","volume":"34","author":"Zhang","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"R22-20260223","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/jcm7100305","article-title":"Serum urokinase-type plasminogen activator receptor does not outperform c-reactive protein and procalcitonin as an early marker of severity of acute pancreatitis.","volume":"7","author":"Kolber","year":"2018","journal-title":"J Clin Med"},{"key":"R23-20260223","first-page":"57","article-title":"Neutrophil to lymphocyte ratio at the early phase of acute pancreatitis correlates with serum urokinase-type plasminogen activator receptor and interleukin 6 and predicts organ failure.","volume":"58","author":"Kolber","year":"2018","journal-title":"Folia Med Cracov"},{"key":"R24-20260223","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3906\/sag-1709-134","article-title":"The role of soluble urokinase plasminogen activator receptor (SuPAR) as an indicator of the severity of acute pancreatitis.","volume":"48","author":"K\u00fc\u00e7\u00fckceran","year":"2018","journal-title":"Turk J Med Sci"},{"key":"R25-20260223","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0039-6060(98)70078-9","article-title":"The plasminogen activator\/plasmin system is up regulated after acute necrotizing pancreatitis in human beings.","volume":"124","author":"Friess","year":"1998","journal-title":"Surgery"},{"key":"R27-20260223","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(14)60649-8","article-title":"Acute pancreatitis.","volume":"386","author":"Lankisch","year":"2015","journal-title":"Lancet"},{"key":"R28-20260223","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2020.20317","article-title":"Acute pancreatitis: a review.","volume":"325","author":"Mederos","year":"2021","journal-title":"JAMA"},{"key":"R29-20260223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-022-02300-2","article-title":"Predictive value of suPAR in AKI: a systematic review and meta-analysis.","volume":"27","author":"Huang","year":"2023","journal-title":"Clin Exp Nephrol"},{"key":"R30-20260223","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/SHK.0000000000001434","article-title":"The diagnostic and prognostic value of suPAR in patients with sepsis: a systematic review and meta-analysis.","volume":"53","author":"Huang","year":"2020","journal-title":"Shock"},{"key":"R31-20260223","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7754\/Clin.Lab.2017.170110","article-title":"Prognostic role of circulating soluble uPAR in various cancers: a systematic review and meta-analysis.","volume":"63","author":"Liu","year":"2017","journal-title":"Clin Lab"},{"key":"R32-20260223","first-page":"1293","article-title":"suPAR: a new biomarker for cardiovascular disease?","volume":"31","author":"Hodges","year":"2015","journal-title":"Can J Cardiol"},{"key":"R33-20260223","first-page":"35","article-title":"Plasma soluble urokinase plasminogen activator receptor levels in systemic lupus erythematosus patients.","volume":"25","author":"Zaitoon","year":"2018","journal-title":"Egypt J Immunol"},{"key":"R34-20260223","doi-asserted-by":"crossref","first-page":"e13794","DOI":"10.1111\/eci.13794","article-title":"Circulating suPAR associates with severity and in-hospital progression of COVID-19.","volume":"52","author":"Chalkias","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"R35-20260223","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00508-015-0886-4","article-title":"Serum soluble urokinase-type plasminogen activator receptor and interferon-\u03b3-induced protein 10 levels correlate with significant fibrosis in chronic hepatitis B.","volume":"128","author":"Sevgi","year":"2016","journal-title":"Wien Klin Wochenschr"},{"key":"R36-20260223","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40265-022-01766-4","article-title":"Acute pancreatitis: diagnosis and treatment.","volume":"82","author":"Szatmary","year":"2022","journal-title":"Drugs"},{"key":"R37-20260223","doi-asserted-by":"crossref","first-page":"g4859","DOI":"10.1136\/bmj.g4859","article-title":"Acute pancreatitis.","volume":"349","author":"Johnson","year":"2014","journal-title":"BMJ"},{"key":"R38-20260223","first-page":"413","article-title":"Mortality prognostic factors in acute pancreatitis.","volume":"9","author":"Popa","year":"2016","journal-title":"J Med Life"},{"key":"R39-20260223","doi-asserted-by":"crossref","first-page":"e13867","DOI":"10.1111\/eci.13867","article-title":"Prognostic value of soluble urokinase-type plasminogen activator receptor in coronary artery disease: a meta-analysis.","volume":"52","author":"Li","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"R40-20260223","doi-asserted-by":"crossref","first-page":"791716","DOI":"10.3389\/fmed.2021.791716","article-title":"Soluble Urokinase Plasminogen Activator Receptor (suPAR) independently predicts severity and length of hospitalisation in patients with COVID-19.","volume":"8","author":"Enocsson","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R41-20260223","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00134-012-2613-1","article-title":"Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review.","volume":"38","author":"Backes","year":"2012","journal-title":"Intensive Care Med"},{"key":"R42-20260223","doi-asserted-by":"crossref","first-page":"1753466620938546","DOI":"10.1177\/1753466620938546","article-title":"The clinical value of suPAR in diagnosis and prediction for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.","volume":"14","author":"Huang","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"R43-20260223","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/00365521.2020.1849383","article-title":"Plasma suPAR may help to distinguish between chronic pancreatitis and pancreatic cancer.","volume":"56","author":"Aronen","year":"2021","journal-title":"Scand J Gastroenterol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:01:52Z","timestamp":1771884112000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":40,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037064","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}